Early administration of dapagliflozin preserves pancreatic β‐cell mass through a legacy effect in a mouse model of type 2 diabetes

Ayumi Kanno(Diabetes Australia), Yoshiaki Kido(Kobe University), Shoko Tsuchiya(Hyogo University of Health Sciences), Tomokazu Matsuda(Kobe University), Shun‐ichiro Asahara(Kobe University), Yuko Okada(Kobe University), Ayuko Furubayashi(Hyogo University of Health Sciences), Emi Suzuki(Kobe University), Mao Kawamura(Hyogo University of Health Sciences), Maki Koyanagi‐Kimura(Kobe University), Tomoko Takai(Kobe University), Wataru Ogawa(Kobe University)
Journal of Diabetes Investigation
October 6, 2018
Cited by 39


Related Papers